Topics

Foamix’s rosacea drug FMX103 splits views on sunburn risk

12:28 EST 10 Dec 2018 | Pharmaceutical Technology

Foamix Pharmaceuticals’ FMX103 (1.5% topical minocycline foam) has experts split over the drug’s real-world ability to protect against sunburn, despite...
Read More...

The post Foamix’s rosacea drug FMX103 splits views on sunburn risk appeared first on Pharmaceutical Technology.

Original Article: Foamix’s rosacea drug FMX103 splits views on sunburn risk

NEXT ARTICLE

More From BioPortfolio on "Foamix’s rosacea drug FMX103 splits views on sunburn risk"

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...